WallStreetZenWallStreetZen

NASDAQ: GILD
Gilead Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GILD

Based on 10 analysts offering 12 month price targets for Gilead Sciences Inc.
Min Forecast
$84.00+7.84%
Avg Forecast
$94.20+20.94%
Max Forecast
$112.00+43.79%

Should I buy or sell GILD stock?

Based on 10 analysts offering ratings for Gilead Sciences Inc.
Buy
Strong Buy
3 analysts 30%
Buy
1 analysts 10%
Hold
6 analysts 60%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GILD stock forecasts and price targets.

GILD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
BMO Capital
Bottom 9%
9
BuyUpgrades$100.00+28.39%2023-05-16
Morgan Stanley
Bottom 15%
15
HoldMaintains$86.00+10.41%2023-05-01
RBC Capital
Top 2%
99
HoldMaintains$88.00+12.98%2023-04-28
Piper Sandler
Bottom 8%
8
Strong BuyAssumes$105.00+34.81%2023-04-28
Mizuho
Bottom 6%
6
Strong BuyMaintains$101.00+29.67%2023-02-14
SVB Leerink
Top 7%
94
HoldMaintains$91.00+16.83%2023-02-03
Piper Sandler
Bottom 10%
10
Strong BuyMaintains$112.00+43.79%2023-02-03
Barclays
Top 32%
69
HoldMaintains$84.00+7.84%2023-01-18
Wells Fargo
Top 12%
89
HoldMaintains$90.00+15.55%2023-01-03
Bank of America
Bottom 10%
10
HoldReinstates$85.00+9.13%2022-12-13

1 of 1

Forecast return on equity

Is GILD forecast to generate an efficient return?
Company
N/A
Industry
14.33%
Market
71.96%

Forecast return on assets

Is GILD forecast to generate an efficient return on assets?
Company
N/A
Industry
5.9%

GILD earnings growth forecast

How is GILD forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
14.12%
Industry
27.44%
Market
25.64%
GILD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GILD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GILD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GILD revenue growth forecast

How is GILD forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
-2.18%
Industry
3.89%
Market
8.43%
GILD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GILD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GILD vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
GILD$77.89$94.20+20.94%Buy
AMGN$218.07$260.10+19.27%Hold
GSK$34.11N/AN/A
SNY$51.01$60.00+17.62%Strong Buy
BMY$65.66$76.13+15.94%Buy
View Top General Drug Manufacturer Stocks

Gilead Sciences Stock Forecast FAQ

Is Gilead Sciences Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: GILD) stock is to Buy GILD stock.

Out of 10 analysts, 3 (30%) are recommending GILD as a Strong Buy, 1 (10%) are recommending GILD as a Buy, 6 (60%) are recommending GILD as a Hold, 0 (0%) are recommending GILD as a Sell, and 0 (0%) are recommending GILD as a Strong Sell.

If you're new to stock investing, here's how to buy Gilead Sciences stock.

What is GILD's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: GILD) forecast ROE is N/A, which is considered weak.

What is GILD's Price Target?

According to 10 Wall Street analysts that have issued a 1 year GILD price target, the average GILD price target is $94.20, with the highest GILD stock price forecast at $112.00 and the lowest GILD stock price forecast at $84.00.

On average, Wall Street analysts predict that Gilead Sciences's share price could reach $94.20 by May 16, 2024. The average Gilead Sciences stock price prediction forecasts a potential upside of 20.94% from the current GILD share price of $77.89.

What is GILD's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: GILD) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 5.9%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.